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Endoplasmic reticulum stress-mediated apoptosis plays an important role in the destruction of pancreatic β-cells and contributes
to the development of type 1 diabetes. The present study examined the eﬀect of KIOM-4, a mixture of four plant extracts, on
streptozotocin- (STZ-) induced endoplasmic reticulum (ER) stress in rat pancreatic β-cells (RINm5F). KIOM-4 was found to
inhibit STZ-induced apoptotic cell death, conﬁrmed by formation of apoptotic bodies and DNA fragmentation. STZ was found
to induce the characteristics of ER stress; mitochondrial Ca
2+ overloading, enhanced ER staining, release of glucose-regulated
protein 78 (GRP78), phosphorylation of RNA-dependent protein kinase (PKR) like ER kinase (PERK) and eukaryotic initiation
factor-2α (eIF-2α), cleavage of activating transcription factor 6 (ATF6) and caspase 12, and upregulation of CCAAT/enhancer-
bindingprotein-homologousprotein(CHOP).However,KIOM-4attenuatedthesechangesinducedbySTZ.Furthermore,KIOM-
4 suppressed apoptosis induced by STZ in CHOP downregulated cells using CHOP siRNA. These results suggest that KIOM-4
exhibits protective eﬀects in STZ-induced pancreatic β-cell damage, by interrupting the ER stress-mediated pathway.
1.Introduction
KIOM-4 is a combination of extracts obtained from Mag-
nolia oﬃcinalis, Pueraria lobata, Glycyrrhiza uralensis, and
Euphorbia pekinensis. Magnolia oﬃcinalisexhibits anticancer,
antimutagenic, hepatoprotective, neuroprotective, antiin-
ﬂammatory and antimicrobial activities [1–7]. Pueraria
lobata possesses antiatherogenic, antimutagenic, antidia-
betic, and antioxidant properties [8–11]. Glycyrrhiza uralen-
sis possesses detoxifying, antioxidant [12], antiulcer, anti-
inﬂammatory, antiviral, antiatherogenic, anticarcinogenic
properties [13], and cytoprotective eﬀect against hepato-
toxicity [14]. Euphorbia pekinensis is widely distributed in
northeast mainland China and its roots have been used
as traditional folk medicine for the treatment of edema,
and shown to possess antiviral and cytotoxic properties
[15, 16]. We recently demonstrated that KIOM-4 exhibits
cytoprotective eﬀectsagainst streptozotocin- (STZ-) induced
oxidative stress damage in β-cells through catalase activation
[17] and heme oxygenase-1 [18], and protects cells against
STZ-induced mitochondrial damage in pancreatic β-cells
through its antioxidant properties [19].
Type 1 diabetes results from autoimmune and/or inﬂam-
matry processes that selectively disrupt insulin-producing
pancreatic β-cell, and is characterized by hyperglycemia due
to reduced insulin secretion. Apoptosis is considered to
be the main mode of pancreatic β-cell death in diabetes
[20, 21]. One of the characteristic features of β-cells is a
highly developed endoplasmic reticulum (ER), apparently
due to heavy engagement in insulin secretion, as the early
steps of insulin biosynthesis occur in the ER [22, 23]. ER
is the site for folding and assembling proteins, lipid biosyn-
thesis, vesicular traﬃc, and cellular calcium storage, and is
sensitive to alterations in homeostasis. Proper ER function
is essential to cell survival and perturbation of its function
induces cellular damage and results in apoptosis. Various
conditions can disturb ER functions and these conditions
include inhibition of protein glycosylation, reduction of2 Evidence-Based Complementary and Alternative Medicine
disulﬁde bond formation, calcium depletion from the ER
lumen, impairment of protein transport from the ER to
the Golgi apparatus, and expression of misfolded proteins.
SuchdysfunctioncausesproteotoxicityintheER,collectively
termed ER stress [24–26]. Recent studies suggest that ER
stress plays an important role in the loss of β-cells [26–28].
Given that ER is a unique oxidizing folding-environment
that favors disulﬁde bond formation, any change in cell
redox state can triggers ER stress and parallel antioxidants
protect cells from ER stress [29]. Furthermore, it has been
suggested that the accumulation of misfolded protein within
the lumen of the ER leads to ER stress, which in turn
causes oxidative stress and ﬁnally cell death [30]. Recent
research also revealed that antioxidants, such as butylated
hydroxyanisole, could reduce ER stress [31]. Therefore,
in present study, we hypothesized that the cytoprotective
mechanism of KIOM-4 against STZ-induced pancreatic β-
cells damage may be involved in interrupting ER stress-
mediated apoptotic pathway.
2.MaterialsandMethods
2.1. Preparation of KIOM-4. The KIOM-4 was provided by
JinSookKimPhDoftheKoreaInstituteofOrientalMedicine
(Daejeon, Korea). It was dissolved in dimethyl sulfoxide
(DMSO), the ﬁnal concentration of which did not exceed
0.1%.
2.2. Reagents. STZ was purchased from Calbiochem (San
Diego, CA). Hoechst 33342 and [3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium] bromide (MTT) were pur-
chased from Sigma Chemical Company (St. Louis, MO).
ER-Tracker Blue-White DPX and Rhod-2 acetoxymethyl
ester (Rhod-2 AM) were purchased from Molecular Probes
(Eugene, OR). Anti-CCAAT/enhancer-binding protein-
homologous protein (CHOP), -capsase 12, -activating
transcription factor 6 (ATF6), and β-actin antibodies were
purchased from Cell Signaling Technology (Beverly, MA).
Antiphospho eukaryotic initiation factor-2α (eIF-2α),
glucose-regulated protein 78 (GRP78), and phospho-RNA-
dependent protein kinase (PKR) like ER kinase (PERK)
antibodies were purchased from Santa Cruz Biotechnology
(Santa Cruz, CA). The other chemicals and reagents were of
analytical grade.
2.3. Cell Culture. RINm5F rat pancreatic β-cells were main-
tainedat37◦Cinanincubatorwithahumidiﬁedatmosphere
of 5% CO2, and cultured in RPMI 1640 medium con-
taining 10% heat-inactivated fetal calf serum, streptomycin
(100μg/mL), and penicillin (100units/mL).
2.4. Cell Viability Assays. Cells were seeded in a 96 well
plate at a concentration of 1 × 105 cells/mL and were treated
with KIOM-4 at 50μg/mL. After 1 hour, 10mM of STZ was
added, and the mixture was incubated for 24 hours. Fifty
μL of the MTT stock solution (2mg/mL) was then added
into each well to attain a total reaction volume of 200μL.
After incubating for 4 hours, the plate was centrifuged
at 800 × g for 5 minutes, and the supernatants were
aspirated. The formazan crystals in each well were dissolved
in 150μLo fD M S Oa n dr e a da tA 540 on a scanning multiwell
spectrophotometer [32, 33].
2.5. Nuclear Staining with Hoechst 33342. Cells were placed
in a 24 well plate at 2 × 105 cells/well. At 16 hours
after plating, cells were treated with 50μg/mL of KIOM-4
and after further incubation for 1 hour, 10mM STZ was
added to the culture. After 24 hours, 1.5μL of Hoechst
33342 (stock 10mg/mL), a DNA-speciﬁc ﬂuorescent dye,
was added to each well (ﬁnal 15μg/mL) and incubated for
10 minutes at 37◦C. The stained cells were then observed
under a ﬂuorescent microscope, which was equipped with a
CoolSNAP-Pro color digital camera, to examine the extent of
nuclear condensation.
2.6. DNA Fragmentation. Cellular DNA fragmentation was
assessed by cytoplasmic histone-associated DNA fragmen-
tation kit from Roche Diagnostics (Mannheim, Germany)
according to the manufacturer’s instructions.
2.7. Mitochondrial Ca2+ Measurements. Rhod-2 AM probe
wasusedtodeterminemitochondrialCa2+ level[34].Rhod-2
AM has a net positive charge, which facilitates its sequestra-
tion into mitochondria due to membrane potential-driven
uptake. The use of Rhod-2 AM enhances the selectivity
for mitochondrial loading, because this dye exhibits Ca2+-
dependent ﬂuorescence only after it is oxidized, and this
occurs preferentially within the mitochondria. Cells were
seeded in a 6 well plate at 1 × 105 cells/mL and were treated
with KIOM-4 at 50μg/mL. After 1 hour, 10mM of STZ was
added, and the mixture was incubated for 24 hours. Cells
were harvested, washed, and suspended in PBS containing
Rhod-2 AM (1μM). After 15 minutes of incubation at 37◦C,
the cells were washed, suspended in PBS, and analyzed by
ﬂow cytometry.
2.8. Fluorescent Microscopy and Staining. Image analysis for
ER staining was achieved by seeding cells on a cover-slip
loaded six well plate at 1 × 105 cells/mL. Sixteen hours
after plating, cells were treated with KIOM-4. One hour
following KIOM-4 treatment, STZ at 10mM, thapsigargin
at 2μg/mL, or tunicamycin at 2μg/mL was added to the
plates,respectively.Twentyfourhourslater,ER-TrackerBlue-
White DPX probe was added to the cells and incubated for
30 minutes under the same growth conditions. The loading
solution was removed and cells were then washed with PBS.
Microscopic images were collected using the Laser Scanning
Microscope 5 PASCAL program (Carl Zeiss, Jena, Germany)
on a confocal microscope.
2.9. Western Blot Analysis. Aliquots of the lysates (40μgo f
protein) were boiled for 5 minutes and electrophoresed on a
10% SDS-polyacrylamide gel. Blots in the gels were trans-
ferred onto nitrocellulose membranes (Bio-Rad, Hercules,
CA), which were then incubated with primary antibodies.
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antibody-horseradish peroxidase conjugates (Pierce, Rock-
land, IL), and exposed to X-ray ﬁlm. Protein bands were
detected using an enhanced chemiluminescence Western
blotting detection kit (Amersham, Little Chalfont, Bucking-
hamshire, UK).
2.10. Transient Transfection of Small RNA Interference
(siRNA). Cells were seeded at 1.5 × 105 cells/well in 24 well
plate and allowed to reach approximately 50% conﬂuence
on the day of transfection. The siRNA construct used
was obtained as mismatched siRNA control (siControl,
Santa Cruz Biotechnology, Santa Cruz, CA) and siRNA
against CHOP (siCHOP, Bioneer Corporation, Bioneer,
South Korea). Cells were transfected with 10–50nM siRNA
using lipofectamineTM 2000 (Invitrogen, Carlsbad, CA)
according to the manufacturer’s instruction. At 24 hours
after transfection, cells were treated with or without KIOM-
4 and/or STZ for 24 hours and examined by Hoechst 33342
staining and DNA fragmentation, respectively.
2.11. Statistical Analysis. All the measurements were made
in triplicate and all values are represented as the mean ±
standard error of the mean (SEM). Data were subjected to
an analysis of the variance (ANOVA) using the Tukey test to
analyze the diﬀerence. P<. 05 was considered statistically
signiﬁcant.
3. Results
3.1. Attenuated Characteristics of Apoptosis in RINm5F Cells
Exposed to STZ by KIOM-4 Treatment. To investigate the
potential role of KIOM-4 on STZ induced β-cells damage,
we ﬁrst examined the eﬀects of KIOM-4 on cell survival. As
shown in Figure 1(a), KIOM-4 signiﬁcantly inhibited STZ-
induced cell damage. In addition, apoptosis was determined
by morphological microscopy after staining of cellular nuclei
with Hoechst 33342. The microscopic images in Figure 1(b)
indicate that the control cells retained intact nuclei, while
STZ-treated cells showed signiﬁcant nuclear fragmentation,
which is characteristic of apoptosis, while KIOM-4 reduced
it. STZ dramatically increased the levels of DNA frag-
mentation compared to control, while KIOM-4 treatment
attenuated STZ-induced DNA fragmentation (Figure 1(c)).
Taken together, these results indicate that KIOM-4 protects
cell viability by inhibiting STZ- induced apoptosis.
3.2. Reduction of STZ-Induced Mitochondrial Ca2+ Overload-
ing and ER Stress by KIOM-4 Treatment. Depletion of ER
calcium stores can induce ER stress [35], which leads to
an increase in mitochondrial Ca2+ [36]. We assessed the
eﬀects of KIOM-4 on mitochondrial Ca2+ mobilization. As
shown in Figure 2(a), STZ treatment resulted in a signiﬁcant
increase in mitochondrial Ca2+ levels at 24 hours, while
KIOM-4 treatment reduced STZ-induced mitochondrial
Ca2+ overloading. Thapsigargin, which selectively inhibits
the Ca2+-ATPase responsible for Ca2+ accumulation of ER,
and tunicamycin, which blocks N-linked protein glycosy-
lationare, are well known for their capacity to induce ER
stress [37, 38]. Recently, ER stress by thapsigargin has
been shown to increase ﬂuorescent intensity of the dye
followingERstainingwithER-TrackerBlue-WhiteDPX[39].
KIOM-4 signiﬁcantly attenuated the staining intensity of
this dye increased by STZ treatment (Figure 2(b)). In our
study, KIOM-4 also reduced the ﬂuorescent intensity of ER
staining, which is induced by thapsigargin (Figure 2(c)),
while KIOM-4 did not show the capacity to reduce the
ﬂuorescent intensity increased by tunicamycin (data not
shown).
Increased PERK phosphorylation and upregulation of
GRP78 are major indicators of ER stress [35]. eIF-2α is
phosphorylated by PERK in response to ER stress, leading to
attenuation of translational initiation and protein synthesis
[40, 41]. Therefore, we examined whether the eﬀects of
KIOM-4 on STZ-induced β-cell damage is associated with
the GRP78 and PERK/eIF-2α kinase signaling pathway. STZ
treatment induced a dramatic increase in GRP78, phospho-
rylated PERK and eIF-2α levels, and KIOM-4 attenuated
these changes (Figure 3). Another hallmark of ER stress
responses include ATF6 activation (cleaved form of ATF6)
and subsequent induction of CHOP [42, 43]. STZ enhanced
ATF6 activation and induced CHOP expression, while
KIOM-4 abolished these changes (Figure 3). Caspase 12 has
been reported to become activated during ER stress [35].
KIOM-4 treatment also attenuated STZ induced activation
ofcaspase12(cleavedformofcaspase12)followingERstress
(Figure 3). These results suggest that ER stress-mediated
apoptosis was involved in the STZ-treated cells, and KIOM-4
inhibited these changes.
3.3. Suppression of Cell Death Induced by STZ in CHOP
Downregulated Cells by KIOM-4 Treatment. CHOP is
reported to play a proapoptotic role during ER stress [42].
To investigate whether CHOP is directly involved in STZ-
induced apoptosis, we employed siRNA against CHOP
mRNA. As shown in Figures 4(a) and 4(b), suppressed
CHOP expression were shown to further alleviate apoptotic
phenomena in STZ-treated or KIOM-4 plus STZ-treated
siCHOP cells, compared to STZ-treated or KIOM-4 plus
STZ-treated siControl cells. These results suggest that CHOP
may be in part involved in STZ-induced apoptosis which is
m e d i a t e db yE Rs t r e s sp a t h w a y .
4. Discussion
ER stress plays a key role in the pathogenesis of diabetes,
contributing to pancreatic β-cell loss and insulin resistance
[20]. Baseline of ER stress in β-cells is higher than in
other cell types, because of their exposure to frequent
energyﬂuctuationsandtheearlystepsofinsulinbiosynthesis
occur in ER [22, 23]. Numerous studies have reported
that antioxidant treatment, which targets oxidative stress,
may help prevent or delay the development of diabetes
and its complications [44, 45]. In our study, KIOM-4
exhibited antioxidant eﬀects by activating catalase, heme
oxygenase-1, and manganese superoxide dismutase [17–
19]. In this context, the antidiabetic eﬀects of KIOM-44 Evidence-Based Complementary and Alternative Medicine
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Figure 1: The eﬀects of KIOM-4 on STZ-induced cell damage. RINm5F cells were treated with KIOM-4 at 50μg/mL, after 1 hour, 10mM
of STZ was added and was incubated for 24 hours. (a) Cell viability was measured using MTT assay. ∗Signiﬁcantly diﬀerent from control
cells (P<. 05). ∗∗Signiﬁcantly diﬀerent from STZ-treated cells (P<. 05). (b) Apoptotic body formation was observed under a ﬂuorescence
microscope after Hoechst 33342 staining (original magniﬁcation, x400). Arrows indicate apoptotic bodies. (c) DNA fragmentation was
quantiﬁed with an ELISA kit. Measurements were made in triplicate and the values are expressed as means ± SEM. ∗Signiﬁcantly diﬀerent
from control cells (P<. 05) and ∗∗signiﬁcantly diﬀerent from STZ-treated cells (P<. 05).Evidence-Based Complementary and Alternative Medicine 5
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Figure 2:TheeﬀectsofKIOM-4onSTZ-inducedmitochondrialCa2+ overloadingandERstaining.Cellsweretreatedwithﬂuorescentprobe
Rhod-2 AM. The mitochondrial Ca2+ levels were measured by (a) ﬂow cytometry as described in Section 2. FI indicates the ﬂuorescence
intensity of Rhod-2 AM. ((b) and (c)) Cells were treated with ER Tracker Blue-White DPX for ER staining as describe in Section 2.6 Evidence-Based Complementary and Alternative Medicine
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Figure 3: The eﬀects of KIOM-4 on STZ-induced ER stress. The expression of GRP78, PERK and its downstream eIF-2α phosphorylation
as well as cleaved ATF6, capsase 12, and CHOP were determined by western blotting analysis.
on ER stress induced by STZ treatment in pancreatic β-
cells were elucidated. Because elevation of mitochondrial
Ca2+ levels or depletion of ER Ca2+ stores is involved
in ER stress-mediated apoptosis, we revealed that STZ-
induced mitochondrial Ca2+ overloading, indicating that
alteration in Ca2+ homeostasis is implicated in STZ-induced
apoptosis, while KIOM-4 treatment restored STZ-induced
mitochondrial Ca2+ overloading. Moreover, recent studies
suggest that increasing the ﬂuorescent intensity following ER
staining with ER-Tracker Blue-White DPX was considered a
character of ER stress [37,46].Inourstudy,STZsigniﬁcantly
increased the staining intensity of this dye, while KIOM-
4 attenuated the increased staining intensity. We further
investigated speciﬁc markers of ER stress. The unfolded
protein response of mammalian cells is initiated by three ER
transmembrane proteins; PERK, IRE1, and ATF6. Many ER
resident proteins display altered expression pattern under ER
stress. Under unstressed conditions, the luminal domains of
these sensors are occupied by the ER chaperon GRP78 [47–
49]. Upon ER stress, sequestration of GRP78 by unfolded
proteins activates these sensors by inducing phosphorylation
and homodimerization of PERK and IRE1, and relocation
and proteolytic cleavage of ATF6 [45–47]. These three ER
stress sensors trigger divergent and convergent signaling
cascades, leading to adaptation or cell death [50]. Our
study found that STZ-induced GRP78 release, PERK phos-
phorylation, and ATF6 cleavage while KIOM-4 inhibited
these altered expression pattern in ER stress. Therefore, we
speculated that the suppression of PERK phosphorylation
and ATF6 cleavage by KIOM-4 treatment was mainly due
to inhibition of GRP78 release. eIF-2α is phosphorylated by
PERK in response to ER stress, leading to attenuation of
translational initiation and protein synthesis [40, 41]. We
also revealed that KIOM-4 attenuated STZ-induced eIF-2α
phosphorylation. Caspase-12 has been reported to become
activated during ER stress [35]. STZ treatment increases
the activation of caspase-12 located in the cytoplasmic side
of ER, while KIOM-4 inhibited caspase-12 activation [35].
CHOP protein was ﬁrst identiﬁed to be a member of the
CCAAT/enhancer binding proteins (C/EBPs) that dimerize
with transcription factors C/EBP and Liver-enriched activa-
tion protein, and functions as a dominant-negative inhibitor
of gene transcription [42]. CHOP is either not expressed
or is expressed at low levels under physiological conditions,
but is strongly induced in response to ER stress at the level
of transcription [51]. Over-expression of CHOP leads to
growth arrest and apoptosis [52–54]. CHOP knockout mice
show normal development and fertility, but exhibit reduced
apoptosisinresponsetoERstress[55–57].Therefore,CHOP
plays an important role in the induction of ER stress-
mediatedapoptosis[55,58].Weobservedthatsuppressionof
CHOP by CHOP siRNA attenuated STZ-induced apoptosis,
suggesting that ER stress may be of importance for the
cytotoxicactivityofSTZ.KIOM-4treatmentfurtherreversed
STZ-induced apoptosis in CHOP siRNA transfected cells,
compared to control siRNA transfected cells. Hence, these
results suggest that KIOM-4 protects against STZ-induced
apoptosis in diabetic pancreatic β-cells via inhibition of ER
stress.
Taken together, this study demonstrated that KIOM-4
protected against STZ-induced β-cell damage via inhibition
of ER stress-mediated apoptosis (Figure 5).Evidence-Based Complementary and Alternative Medicine 7
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Figure 4: The eﬀects of KIOM-4 on cell death induced by STZ in CHOP-downregulated cells. (a) Cells were transfected with CHOP siRNA
or control siRNA, the transfected cells were treated with KIOM-4 at 50μg/mL. After 1 hour, 10mM of STZ was added and further incubated
for 24 hours. (a) Apoptotic body formation was observed under a ﬂuorescence microscope and quantitated after Hoechst 33342 staining
(original magniﬁcation x400). Arrows indicate apoptotic bodies. ∗Signiﬁcantly diﬀerent between STZ-treated siControl and STZ-treated
siCHOP (P<. 05) and ∗∗signiﬁcantly diﬀerent between KIOM-4 plus STZ-treated siControl and KIOM-4 plus STZ-treated siCHOP cells
(P<. 05). (b) DNA fragmentation was quantiﬁed with an ELISA kit. Measurements were made in triplicate and values are expressed as
means ± SEM. ∗Signiﬁcantly diﬀerent between STZ-treated siControl and STZ-treated siCHOP (P<. 05), and ∗∗signiﬁcantly diﬀerent
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Figure 5:ModelillustratingtheinhibitoryeﬀectofKIOM-4against
STZ-induced ER stress pathway.
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